David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Southwest Airlines Shareholders Should Brace for Turbulence Amid Worker Shortage

By David Moadel, InvestorPlace Contributor

Even as the incoming Southwest CEO boasts about recent bookings figures, LUV stock could buckle under the pressure of flight cancellations.

Vinco Ventures Stock Is Like an Incredibly Volatile Box of Chocolates

By David Moadel, InvestorPlace Contributor

Vinco Ventures always seems to be making deals - and a recent crypto-centered joint venture makes BBIG stock all the more interesting.

Upstart Stock Has a Valuation Issue That Eclipses Any Upside Thesis

By David Moadel, InvestorPlace Contributor

UPST stock seems to have gotten ahead of itself, but patient investors can wait as the AI-powered fintech company definitely has potential.

Take the Green Blockchain to the Next Level with Cardano

By David Moadel, InvestorPlace Contributor

As the data shows, you'll be in good company with millions of Cardano holders if you take a position in this still-cheap crypto coin.

Sell-the-News Moment Is Your Chance to Reload on Ocugen

By David Moadel, InvestorPlace Contributor

As Ocugen - or at least, a partner in developing a Covid-19 vaccine - receives a critical approval, OCGN stock could rebound soon.

Load More